Interpretation and the infrastructure around it, so labs that already sequence can offer more analyses under their own brand.
Today GIAS takes raw data to annotation, with reporting next. The rest of this page is where it's going, not a finished product.
Somatic first, then RNA-seq. Later, proteomics and multi-omics that read DNA, blood and gut together.
Sequencing runs at our partner labs in India. On uncertain results, a human decides.
Lab heads and business development leads who want to offer more analyses.
